LncITPF Promotes Pulmonary Fibrosis by Targeting HnRNP-L Depending on Its Host Gene ITGBL1

Overview

Journal Mol Ther

Publisher Cell Press

Specialties Molecular Biology
Pharmacology

Date 2018 Dec 12

PMID 30528088

Citations 27

Authors

Xiaodong Song

Pan Xu

Chao Meng

Chenguang Song

Timothy S Blackwell

Rongrong Li

Hongbo Li

Jinjin Zhang

Changjun Lv

Affiliations

Soon will be listed here.

Abstract

The role of long non-coding RNA (lncRNA) in idiopathic pulmonary fibrosis (IPF) is poorly understood. We found a novel lncRNA-ITPF that was upregulated in IPF. Bioinformatics and in vitro translation verified that lncITPF is an actual lncRNA, and its conservation is in evolution. Northern blot and rapid amplification of complementary DNA ends were used to analyze the full-length sequence of lncITPF. RNA fluorescence in situ hybridization and nucleocytoplasmic separation demonstrated that lncITPF was mainly located in the nucleus. RNA sequencing, chromatin immunoprecipitation (ChIP)-qPCR, CRISPR-Cas9 technology, and promoter activity analysis showed that the fibrotic function of lncITPF depends on its host gene integrin β-like 1 (ITGBL1), but they did not share the same promoter and were not co-transcribed. Luciferase activity, pathway inhibitors, and ChIP-qPCR showed that smad2/3 binds to the lncITPF promoter, and TGF-β1-smad2/3 was the upstream inducer of the fibrotic pathway. Furthermore, RNA-protein pull-down, liquid chromatography-mass spectrometry (LC-MS), and protein-RNA immunoprecipitation showed that lncITPF regulated H3 and H4 histone acetylation in the ITGBL1 promoter by targeting heterogeneous nuclear ribonucleoprotein L. Finally, sh-lncITPF was used to evaluate the therapeutic effect of lncITPF. Clinical analysis showed that lncITPF is associated with the clinicopathological features of IPF patients. Our findings provide a therapeutic target or diagnostic biomarker for IPF.

Citing Articles

Integrated analysis of bioinformatics, mendelian randomization, and experimental validation reveals novel diagnostic and therapeutic targets for osteoarthritis: progesterone as a potential therapeutic agent.

Weng Z, Wang C, Liu B, Yang Y, Zhang Y, Zhang C J Orthop Surg Res. 2025; 20(1):85.

PMID: 39849508 PMC: 11755849. DOI: 10.1186/s13018-025-05459-y.

Emerging roles of non-coding RNAs in fibroblast to myofibroblast transition and fibrotic diseases.

Xing X, Rodeo S Front Pharmacol. 2024; 15:1423045.

PMID: 39114349 PMC: 11303237. DOI: 10.3389/fphar.2024.1423045.

Pathogenic mycoplasmas of humans regulate the long noncoding RNAs in epithelial cells.

Ramos E, Veerapandian R, Das K, Chacon J, Gadad S, Dhandayuthapani S Noncoding RNA Res. 2023; 8(3):282-293.

PMID: 36970372 PMC: 10031284. DOI: 10.1016/j.ncrna.2023.03.002.

Epigenetics alternation in lung fibrosis and lung cancer.

Li X, Feng C, Peng S Front Cell Dev Biol. 2022; 10:1060201.

PMID: 36420141 PMC: 9676258. DOI: 10.3389/fcell.2022.1060201.

Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF-HuR complex.

Zhu Q, Wang J, Ji Y, Luan J, Yue D, Liu W Front Pharmacol. 2022; 13:1013098.

PMID: 36386240 PMC: 9664248. DOI: 10.3389/fphar.2022.1013098.

References

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

Meseure D, Alsibai K, Nicolas A, Bieche I, Morillon A . Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets. Biomed Res Int. 2015; 2015:320214. PMC: 4584070. DOI: 10.1155/2015/320214. View

Hao X, Du Y, Qian L, Li D, Liu X . Upregulation of long noncoding RNA AP003419.16 predicts high risk of aging‑associated idiopathic pulmonary fibrosis. Mol Med Rep. 2017; 16(6):8085-8091. PMC: 5779893. DOI: 10.3892/mmr.2017.7607. View

Yang X, Song J, Cheng Y, Wu W, Bhagat T, Yu Y . Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut. 2013; 63(6):881-90. PMC: 4612639. DOI: 10.1136/gutjnl-2013-305266. View

Li Z, Chao T, Chang K, Lin N, Patil V, Shimizu C . The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A. 2013; 111(3):1002-7. PMC: 3903238. DOI: 10.1073/pnas.1313768111. View

Liao Q, Liu C, Yuan X, Kang S, Miao R, Xiao H . Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res. 2011; 39(9):3864-78. PMC: 3089475. DOI: 10.1093/nar/gkq1348. View

Ruiz-Orera J, Messeguer X, Subirana J, Alba M . Long non-coding RNAs as a source of new peptides. Elife. 2014; 3:e03523. PMC: 4359382. DOI: 10.7554/eLife.03523. View

Gan X, Liu Z, Tong B, Zhou J . Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling. Tumour Biol. 2015; 37(2):1663-9. DOI: 10.1007/s13277-015-3919-8. View

Wu Y, Liu H, Shi X, Yao Y, Yang W, Song Y . The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget. 2015; 6(11):9160-72. PMC: 4496209. DOI: 10.18632/oncotarget.3247. View

10.

Garzon R, Volinia S, Papaioannou D, Nicolet D, Kohlschmidt J, Yan P . Expression and prognostic impact of lncRNAs in acute myeloid leukemia. Proc Natl Acad Sci U S A. 2014; 111(52):18679-84. PMC: 4284555. DOI: 10.1073/pnas.1422050112. View

11.

Semren N, Welk V, Korfei M, Keller I, Fernandez I, Adler H . Regulation of 26S Proteasome Activity in Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015; 192(9):1089-101. DOI: 10.1164/rccm.201412-2270OC. View

12.

Staab-Weijnitz C, Fernandez I, Knuppel L, Maul J, Heinzelmann K, Juan-Guardela B . FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015; 192(4):455-67. PMC: 4595665. DOI: 10.1164/rccm.201412-2233OC. View

13.

Liu Y, Nepali K, Liou J . Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets. J Med Chem. 2017; 60(2):527-553. DOI: 10.1021/acs.jmedchem.6b00935. View

14.

Hung C, Wang L, Yu Y, Chen H, Srivastava S, Petrovics G . A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A. 2014; 111(52):18697-702. PMC: 4284533. DOI: 10.1073/pnas.1415669112. View

15.

Kawakami T, Okamoto K, Ogawa O, Okada Y . XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer. Lancet. 2004; 363(9402):40-2. DOI: 10.1016/S0140-6736(03)15170-7. View

16.

Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M . A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011; 147(2):358-69. PMC: 3234495. DOI: 10.1016/j.cell.2011.09.028. View

17.

Li X, Du X, Li D, Kong P, Sun Y, Liu P . ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway. Cancer Res. 2015; 75(16):3302-13. DOI: 10.1158/0008-5472.CAN-15-0240. View

18.

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H . The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012; 22(9):1775-89. PMC: 3431493. DOI: 10.1101/gr.132159.111. View

19.

Su X, Malouf G, Chen Y, Zhang J, Yao H, Valero V . Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes. Oncotarget. 2014; 5(20):9864-76. PMC: 4259443. DOI: 10.18632/oncotarget.2454. View

20.

Ota C, Yamada M, Fujino N, Motohashi H, Tando Y, Takei Y . Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo. Exp Lung Res. 2015; 41(8):422-34. DOI: 10.3109/01902148.2015.1060275. View